<DOC>
	<DOCNO>NCT00225524</DOCNO>
	<brief_summary>Phase III long-term safety study Effexor XR patient major depression .</brief_summary>
	<brief_title>Study Evaluating Long-Term Safety Effexor XR Patients With Major Depression .</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients complete Phase III doubleblind study ( Protocol Number 0600B1816 ) Patients schizophrenia psychotic disorder Patients history presence bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Depression</keyword>
</DOC>